BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19456251)

  • 1. Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.
    Arnold JJ; Choksi Y; Chen X; Shimazaki A; Hatten J; Toone EJ; Epstein DL; Challa P
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):179-86. PubMed ID: 19456251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new ethacrynic acid derivative SA9000 on intraocular pressure in cats and monkeys.
    Shimazaki A; Ichikawa M; Rao PV; Kirihara T; Konomi K; Epstein DL; Hara H
    Biol Pharm Bull; 2004 Jul; 27(7):1019-24. PubMed ID: 15256733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new ethacrynic acid oxime derivative SA12590 on intraocular pressure in cats and monkeys.
    Shimazaki A; Kirihara T; Rao PV; Tajima H; Matsugi T; Epstein DL
    Biol Pharm Bull; 2007 Aug; 30(8):1445-9. PubMed ID: 17666801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical ethacrynic acid adducts on intraocular pressure in rabbits and monkeys.
    Tingey DP; Schroeder A; Epstein MP; Epstein DL
    Arch Ophthalmol; 1992 May; 110(5):699-702. PubMed ID: 1580849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
    Chien DS; Tang-Liu DD; Woodward DF
    J Pharm Sci; 1997 Oct; 86(10):1180-6. PubMed ID: 9344177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.
    Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M; Nair S; Rui E; Lafontaine J; Almaden CD; Wells P; Krauss A
    Exp Eye Res; 2009 Nov; 89(5):608-17. PubMed ID: 19445930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical ethacrynic acid ointment vs timolol on intraocular pressure in glaucomatous monkey eyes.
    Wang RF; Podos SM; Serle JB; Lee PY; Neufeld AH; Deschenes R
    Arch Ophthalmol; 1994 Mar; 112(3):390-4. PubMed ID: 8129666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.
    Hsu CR; Chen YH; Liu CP; Chen CH; Huang KK; Huang JW; Lin MN; Lin CL; Chen WR; Hsu YL; Lee TC; Chou SH; Tu CM; Hwang CS; Huang YC; Lu DW
    Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):624-633. PubMed ID: 30735565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
    Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
    Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.
    Lin CW; Gonzalez P; Yuan F
    Mol Vis; 2011; 17():2507-15. PubMed ID: 21976961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI; Khedr A; Abdel-Naim AB; Al-Marzoqi A
    J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent.
    Roy Chowdhury U; Pervan-Steel CL; Sheeler R; Sookdeo HK; Rogers B; Casale R; Dosa PI; Htoo T; Wirostko BM; Fautsch MP
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):332-346. PubMed ID: 37200453
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study.
    Alm A; Villumsen J; Törnquist P; Mandahl A; Airaksinen J; Tuulonen A; Marsk A; Resul B; Stjernschantz J
    Ophthalmology; 1993 Sep; 100(9):1312-6; discussion 1316-7. PubMed ID: 8371917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular activity of topically administered anandamide in the rabbit.
    Mikawa Y; Matsuda S; Kanagawa T; Tajika T; Ueda N; Mimura Y
    Jpn J Ophthalmol; 1997; 41(4):217-20. PubMed ID: 9304433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo hydrolysis rates of ethacrynate esters and their relationship to intraocular pressure in the rabbit eye.
    Deshpande G; Schoenwald RD; Barfknecht CF; Duffel MW
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):539-56. PubMed ID: 11132901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.